← Back to Clinical Trials
Recruiting EARLY_Phase 1 NCT06538298

Title: A Multimodal Exercise Program With Gamification for Parkinson Disease (MEP+G)

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Parkinson Disease
Sponsor California State University, Northridge
Study Type INTERVENTIONAL
Phase EARLY_Phase 1
Enrollment 50
Sex ALL
Min Age 40 Years
Max Age 80 Years
Start Date 2024-09-15
Completion 2026-05-26
Interventions
Multimodal Exercise Program with Gamification

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

In this pilot study the research will explore whether exercises and the outcome measures would be acceptable to conduct a more detailed research study. This 8 week pilot study will utilize a comprehensive exercise program that includes non-contact boxing along with computerized games for individuals with Parkinson Disease.

Eligibility Criteria

Inclusion Criteria: * Hoehn and Yahr stages 1-3 disease as determined by primary care physician, neurologist, or movement disorder specialist * diagnosis of idiopathic Parkinson's Disease * ability to ambulate with or without an assistive device * transportation to and from testing site * ability to stand unassisted for 10 minutes * stable on Parkinson's disease medications for 3 months as determined by physician * medical clearance by their PCP, neurologist, or movement disorder specialist to participate in a moderate to vigorous exercise program. Exclusion Criteria: * other neurological disease other than Parkinson's disease * having had deep brain stimulation within the past 3 months , as determined by their physician * currently participating in a Rock Steady boxing program * self-report participation in moderate to vigorous exercise greater than 60 minutes per week. * required

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}